Cell Signaling Technology

Ibrutinib

#16483 · $217

100
Citing papers
6.8k
Combined citations
Supplier page Find this product

Research areas

NF-κB Signaling Pathways15Cytokine Signaling Pathways and Interactions8Immune Response and Inflammation7Protease and Inhibitor Mechanisms7Cell death mechanisms and regulation6Genomics, phytochemicals, and oxidative stress5Cell Adhesion Molecules Research5Protein Kinase Regulation and GTPase Signaling5

Papers citing this product

1
Inhibition of Activator Protein-1, NF-κB, and MAPKs and Induction of Phase 2 Detoxifying Enzyme Activity by Chlorogenic Acid
Journal of Biological Chemistry·2005·388 cit.·DOI
2
D1 Dopamine Receptor Supersensitivity in the Dopamine-Depleted Striatum Results from a Switch in the Regulation of ERK1/2/MAP Kinase
Journal of Neuroscience·2002·367 cit.·DOI
3
S100A8 and S100A9 Induce Cytokine Expression and Regulate the NLRP3 Inflammasome via ROS-Dependent Activation of NF-κB1
PLoS ONE·2013·252 cit.·DOI
4
β-Amyloid-Induced Neuronal Apoptosis Involves c-Jun N-Terminal Kinase-Dependent Downregulation of Bcl-w
Journal of Neuroscience·2005·230 cit.·DOI
5
Cellular ATP demand creates metabolically distinct subpopulations of mitochondria
Nature·2024·229 cit.·DOI
6
Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data
Nucleic Acids Research·2010·212 cit.·DOI
7
Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus
Gastroenterology·2002·204 cit.·DOI
8
Epigallocatechin, a Green Tea Polyphenol, Attenuates Myocardial Ischemia Reperfusion Injury in Rats
Molecular Medicine·2004·181 cit.·DOI
9
Effects of Apigenin on RBL-2H3, RAW264.7, and HaCaT Cells: Anti-Allergic, Anti-Inflammatory, and Skin-Protective Activities
International Journal of Molecular Sciences·2020·180 cit.·DOI
10
Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways
Blood·2005·174 cit.·DOI
Ibrutinib — Evidence — PubIndex